These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8356636)

  • 1. In vitro response to immunosuppressive agents in blacks.
    Ward M; Lazda VA; Gaddis PJ; Stormoen BM; Smith Y; Fabrega AJ; Pollak R
    Transplant Proc; 1993 Aug; 25(4):2470-1. PubMed ID: 8356636
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of some immunosuppressive agents on blastogenesis and target-cell lysis in vitro.
    Cordier G; Roux C; Revillard JP
    Int Arch Allergy Appl Immunol; 1973; 45(1):299-303. PubMed ID: 4269521
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol.
    Hibbins M; Chapman JR
    Transplant Proc; 1992 Feb; 24(1):224-6. PubMed ID: 1539257
    [No Abstract]   [Full Text] [Related]  

  • 4. L-asparaginase and alteration of lymphocyte surface. Inhibition of the rat mixed leukocyte interaction.
    Kahn JM; Fidler IJ
    J Med; 1973; 4(4):248-56. PubMed ID: 4272007
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients.
    Zeevi A; Pavlick M; Lombardozzi S; Banas R; Rao AS; Fontes P; Demetris AJ; Shapiro R; Jordan M; Dodson F
    Transplant Proc; 1995 Feb; 27(1):213-5. PubMed ID: 7533388
    [No Abstract]   [Full Text] [Related]  

  • 6. Annual review of transplantation.
    First MR
    Clin Transpl; 1990; ():357-73. PubMed ID: 2129410
    [No Abstract]   [Full Text] [Related]  

  • 7. Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation.
    Zeevi A; Pavlick M; Banas R; Bentlejewski C; Spichty K; Rao AS; Fontes P; Iyengar A; Shapiro R; Dodson F; Jordan M; Pham S; Keenan R; Griffith B; Corry R; Egidi F; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1205-6. PubMed ID: 9123274
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cyclosporine metabolites and clinical toxicity in organ transplantation.
    Soy D; Campistol JM; Brunet M; Roca M; Carreras E; Andreu H; Codina C; Ribas J
    Transplant Proc; 1995 Aug; 27(4):2415-6. PubMed ID: 7652858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mixed cultures of donor lymphocytes in the course of kidney transplantation].
    Kreth HW; Deicher H; Pichlmayr R
    Bibl Haematol; 1971; 37():70-6. PubMed ID: 4945045
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive effect of bactobolamine on in vitro lymphocyte alloactivation: synergism with cyclosporine.
    Imai T; Inoue S; Kuzuhara K; Hosoya Y; Honda M; Takasaki E; Yoshida KI; Manaka K; Nishimura Y; Bekku Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 2000 Nov; 32(7):2060-2. PubMed ID: 11120066
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunocompetence assay for net effect of combined immunosuppression.
    Nagashima N; Shalabi A; Watanabe T; Ogawa N; Koyama I; Kyo S; Burdick JF
    Transplant Proc; 2001 May; 33(3):2350-1. PubMed ID: 11377556
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells.
    Rao AS; Fontes P; Zeevi A; Trucco M; Dodson FS; Rybka WB; Shapiro R; Jordan M; Pham SM; Rilo HL
    Transplant Proc; 1995 Feb; 27(1):210-2. PubMed ID: 7878975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased effect of immunosuppression on immunocompetence in African--Americans after kidney and liver transplantation.
    Nagashima N; Watanabe T; Nakamura M; Shalabi A; Burdick JF
    Clin Transplant; 2001 Apr; 15(2):111-5. PubMed ID: 11264637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
    Yamashita M; Aikawa A
    Transplant Proc; 2000 Nov; 32(7):1768-72. PubMed ID: 11119927
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue typing--minimum requirements for clinical transplantation.
    Chapman JR
    Transplant Proc; 1992 Oct; 24(5):1674-5. PubMed ID: 1412792
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive effects of bactobolamine in vitro and in vivo.
    Tomikawa S; Beck Y; Watanabe K; Kikuchi K; Ito S; Ando Y; Ichikawa N; Meigata K; Nomura Y; Degawa H; Nagao T; Uchida H
    Transplant Proc; 1996 Apr; 28(2):1049-51. PubMed ID: 8623223
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells.
    Snippe H; Bruijnzeel PL; Willers JM
    Int Arch Allergy Appl Immunol; 1973; 45(5):731-43. PubMed ID: 4270693
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
    Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 20. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I; Yaron R; Oluwole SF; Hardy MA
    Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.